Skip to search formSkip to main contentSkip to account menu

S-1 Antimetabolite agent

Known as: S1, S-1 drug, S1-tegafur-oxonate combination 
An oral fluoropyrimidine antagonist composed of tegafur combined with two modulators of 5-flurouracil (5-FU) activity, 5-chloro-2,4-dihydroxypyridine… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Tujuan dari penelitian ini adalah ingin mengetahui seberapa besar pengaruh pengajaran Mendeley reference management software… 
2017
2017
A phase II study of S‐1 plus leucovorin (LV) given in a 4‐week schedule (2 weeks’ administration followed by 2 weeks’ rest) for… 
2015
2015
SURVEI ENTOMOLOGI DAN PENENTUAN MAYA INDEX DI DAERAH ENDEMIS DBD DI DUSUN KRAPYAK KULON, DESA PANGGUNGHARJO, KECAMATAN SEWON… 
2013
2013
Pendidik professional tidak cukup hanya memiliki ijazah – sebagai penanda kepemilikan modal intelektual, tetapi harus disertai… 
2012
2012
Purpose5-chloro-2,4-dihydroxypyridine (gimeracil) is a component of the oral fluoropyrimidine derivative S-1. Gimeracil was… 
2011
2011
Skripsi merupakan syarat kelulusan bagi mahasiswa jenjang S-1 di prodi PKK, dengan bobot 6 SKS. Kondisi tiga tahun terakhir, masa… 
2009
2009
Background: S-1, a novel oral fluoropyrimidine, is well tolerated in patients with metastatic colorectal cancer (mCRC). The… 
1994
1994
1. The renal effects of inhibiting nitric oxide (NO) formation using N‐nitro‐L‐arginine (NOLA, 20 mg kg‐1) were examined using…